S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q1 2025

Deep Track Capital

Period: Q1 2025 Β· Filed: 2025-05-15
View on SEC EDGAR β†—
AUM
$3.09B
Total portfolio value
Positions
69
Reported securities
Top Holding
ITCI
8.5% $263.8M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ITCIINTRA-CELLULAR THERAPIES INC$263.8M8.54%β€”β€”
8.5%
GHGUARDANT HEALTH INC$231.9M7.51%$42.60$167.98+294.3%
7.5%
DVAXDYNAVAX TECHNOLOGIES CORP$230.8M7.47%β€”β€”
7.5%
IMVTIMMUNOVANT INC$162.3M5.26%$17.09$38.79+127.0%
5.3%
PTGXPROTAGONIST THERAPEUTICS INC$145.1M4.70%$48.36$131.62+172.2%
4.7%
IONSIONIS PHARMACEUTICALS INC$137.7M4.46%$30.17$81.80+171.1%
4.5%
AKROAKERO THERAPEUTICS INC$129.9M4.21%β€”β€”
4.2%
CYTKCYTOKINETICS INC$123.5M4.00%$40.19$86.49+115.2%
4.0%
APLSAPELLIS PHARMACEUTICALS INC$109.3M3.54%$21.87β€”
3.5%
OCULOCULAR THERAPEUTIX INC$104.8M3.39%$7.33$9.64+31.5%
3.4%
BBIOBRIDGEBIO PHARMA INC$96.8M3.13%$34.57$77.19+123.3%
3.1%
TARSTARSUS PHARMACEUTICALS INC$76.3M2.47%$51.37$65.44+27.4%
2.5%
VRDNVIRIDIAN THERAPEUTICS INC$72.5M2.35%$13.48$19.40+43.9%
2.4%
GPCRSTRUCTURE THERAPEUTICS INC$71.0M2.30%$17.31$53.45+208.8%
2.3%
ETNB89BIO INC$67.7M2.19%β€”β€”
2.2%
NRIXNURIX THERAPEUTICS INC$65.3M2.12%$11.88$23.97+101.8%
2.1%
GERNGERON CORP$60.7M1.97%$1.59$1.36-14.5%
2.0%
SRPTSAREPTA THERAPEUTICS INC$57.4M1.86%$63.82$19.28-69.8%
1.9%
RAREULTRAGENYX PHARMACEUTICAL IN$48.9M1.58%$36.21$33.47-7.6%
1.6%
ANIPANI PHARMACEUTICALS INC$46.9M1.52%$66.95$86.03+28.5%
1.5%
DNTHDIANTHUS THERAPEUTICS INC$42.8M1.38%$18.14$94.34+420.1%
1.4%
IMCRIMMUNOCORE HLDGS PLC$41.9M1.36%$29.67$32.50+9.5%
1.4%
CLDXCELLDEX THERAPEUTICS INC NEW$36.3M1.18%$18.15$38.37+111.4%
1.2%
MAZEMAZE THERAPEUTICS INC$36.0M1.17%$11.01$31.26+183.9%
1.2%
AMGNAMGEN INC$35.2M1.14%$299.81$374.15+24.8%
1.1%
XENEXENON PHARMACEUTICALS INC$33.5M1.09%$33.55$60.96+81.7%
1.1%
EWTXEDGEWISE THERAPEUTICS INC$30.8M1.00%$22.00$39.56+79.8%
1.0%
MTSRMETSERA INC$29.8M0.96%β€”β€”
1.0%
PCVXVAXCYTE INC$28.3M0.92%$37.76$58.39+54.6%
0.9%
AUTLAUTOLUS THERAPEUTICS PLC$27.7M0.90%$1.55$1.58+1.9%
0.9%

Quarter-on-Quarter Activity

Q1 2025 vs. Q4 2024

New Positions (8)

TickerIssuerNotionalSince Filing
TARSTARSUS PHARMACEUTICALS INC$76.3M+27.4%
SRPTSAREPTA THERAPEUTICS INC$57.4M-69.8%
DNTHDIANTHUS THERAPEUTICS INC$42.8M+420.1%
MAZEMAZE THERAPEUTICS INC$36.0M+183.9%
AMGNAMGEN INC$35.2M+24.8%
MTSRMETSERA INC$29.8M
PCVXVAXCYTE INC$28.3M+54.6%
CMPSCOMPASS PATHWAYS PLC$25.3M

Exited Positions (8)

TickerIssuerNotional
SWTXSPRINGWORKS THERAPEUTICS INC$125.0M
HRMYHARMONY BIOSCIENCES HLDGS IN$49.9M
NMRANEUMORA THERAPEUTICS INC.$42.4M
GMABGENMAB A/S$41.7M
VRNAVERONA PHARMA PLC$39.5M
CNTACENTESSA PHARMACEUTICALS PLC$22.6M
NMRANEUMORA THERAPEUTICS INC.$12.6M
FDMT4D MOLECULAR THERAPEUTICS IN$3.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
GERNGERON CORP$46.5M+851.7%-14.5%
XENEXENON PHARMACEUTICALS INC$26.9M+491.3%+81.7%
BBIOBRIDGEBIO PHARMA INC$74.3M+241.8%+123.3%
PTGXPROTAGONIST THERAPEUTICS INC$106.5M+200.0%+172.2%
IMCRIMMUNOCORE HLDGS PLC$26.6M+171.7%+9.5%
IONSIONIS PHARMACEUTICALS INC$70.1M+136.0%+171.1%
UPBUPSTREAM BIO INC$-2.4M+130.0%
AKROAKERO THERAPEUTICS INC$88.5M+115.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
BCYCBICYCLE THERAPEUTICS PLC$-11.3M-39.9%
NVAXNOVAVAX INC$-6.3M-24.1%
GHGUARDANT HEALTH INC$35.8M-15.2%+294.3%
MNMDMIND MEDICINE MINDMED INC$-5.0M-11.2%
PLRXPLIANT THERAPEUTICS INC$-71.4M-9.6%
IVVDINVIVYD INC$1.1M-9.0%
LKFTGALAPAGOS NV$-2.9M-5.1%
AVTXAVALO THERAPEUTICS INC$0.5M-0.8%
← Back to Hedge Funds